Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP265536.RAlPiC8RYygRvaazxVJeatTpZC-oKK6h25GPzfPWhV9Kw130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265536.RAlPiC8RYygRvaazxVJeatTpZC-oKK6h25GPzfPWhV9Kw130_provenance.
• NP285045.RAif0-0737XP6TfdlK9AuoLjX2xRasPbumPA9w__W_1SE130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285045.RAif0-0737XP6TfdlK9AuoLjX2xRasPbumPA9w__W_1SE130_provenance.
• NP650496.RAA3FU5C4d2e0Z8hUJXouXG6-MTna0esg1VoNUpBdqcvI130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650496.RAA3FU5C4d2e0Z8hUJXouXG6-MTna0esg1VoNUpBdqcvI130_provenance.
• NP650498.RAA5pJxikwT3McxQKXYwMbevNLVd8qIZSlEjnJAdeveSI130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650498.RAA5pJxikwT3McxQKXYwMbevNLVd8qIZSlEjnJAdeveSI130_provenance.
• NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650494.RAl7gdmvWPOR3RIknnKmTkLPPQoMkk4D2UuO4iOP1CZ3c130_provenance.
• NP650499.RAj_v6aFDjx0XjuPA7nb-6hmM_FABVQOkzs3WICjOgifg130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650499.RAj_v6aFDjx0XjuPA7nb-6hmM_FABVQOkzs3WICjOgifg130_provenance.
• NP284889.RAyUCIn7BWHnA0RJ4puybS-kKt3pum5Y_V_iVZtOvqOYo130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284889.RAyUCIn7BWHnA0RJ4puybS-kKt3pum5Y_V_iVZtOvqOYo130_provenance.
• NP285162.RA1nN81Yu2Y-H9JmB-m_TVO5dTBxbOWj3HVrK0ngnHFgU130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285162.RA1nN81Yu2Y-H9JmB-m_TVO5dTBxbOWj3HVrK0ngnHFgU130_provenance.
• NP265677.RAJ7OAfUMi2P4wFLpVMkHcr61pPPP1ZFogyk-y6YV73cM130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265677.RAJ7OAfUMi2P4wFLpVMkHcr61pPPP1ZFogyk-y6YV73cM130_provenance.
• NP650506.RAMkVyPbcKE3Vm2j-R7fF2OfeWvWPV9caQ-w937BuoZL8130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650506.RAMkVyPbcKE3Vm2j-R7fF2OfeWvWPV9caQ-w937BuoZL8130_provenance.
• NP650501.RA4VkR1_o2qPGftRjw0x2vqyXyWRo1Ewhiy68Q2Iacf0M130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650501.RA4VkR1_o2qPGftRjw0x2vqyXyWRo1Ewhiy68Q2Iacf0M130_provenance.
• NP650503.RAwINNg7SjIAi-DTjOw-135jMU6ZTxQzOaJiusoeLn90Y130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650503.RAwINNg7SjIAi-DTjOw-135jMU6ZTxQzOaJiusoeLn90Y130_provenance.
• NP650504.RA_JSxUIoctTVvd0qWQNRq-8Cudpim36dXq6lzs70UDHc130_assertion description "[Among 18 BCR-ABL+ leukemias presenting acquired trisomy of chromosome 21, we report a high frequency (33%) of recurrent point mutations (4 in myeloid blast crisis [BC] CML and one in chronic phase CML) within the DNA-binding region of RUNX1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650504.RA_JSxUIoctTVvd0qWQNRq-8Cudpim36dXq6lzs70UDHc130_provenance.